AV
Avantor
AVTR·NYSERadnor PAFounded 201013,000 employees
Large CapbiotechPublicOncology
Platform: Lab Products CDMO
Market Cap
$12B
All Drugs
5
Clinical Trials
10
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (AVTR)
Loading AVTR stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| AVT-4398 | AVT-4398 | Phase 3 | 4 | EZH2 | MMAsthma | ||
| Tirasertib | AVT-6752 | Phase 2/3 | 2 | IL-13 | RCCHemophilia A | ||
| Olpazumab | AVT-2308 | Phase 1/2 | 2 | EGFR | MCLNSCLC | ||
| AVT-8949 | AVT-8949 | Phase 3 | 1 | KRASG12C | PAHAngelman | ||
| Teraosocimab | AVT-3685 | Approved | 1 | C5 | NBMS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)